If you would like to learn more about future focusIR related events and roundtables, please submit your details here

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksJpmorgan Clav Regulatory News (JCH)

Share Price Information for Jpmorgan Clav (JCH)

Share Price is delayed by 15 minutes
Get Live Data
942.00    -8.00 (-0.84%)
Bid:
940.00
Ask:
948.00
Spread: 8.00 (0.851%)
Market Cap: £512.55m
JCH Live PriceLast checked at - London Stock Exchange

Intraday Jpmorgan Clav Share Chart

Directorate change

25 Mar 2026 07:00

RNS Number : 9770X
JPMorgan Claverhouse IT PLC
25 March 2026
 

LONDON STOCK EXCHANGE ANNOUNCEMENT

 

 

 JPMORGAN CLAVERHOUSE INVESTMENT TRUST PLC

 

 

APPOINTMENT OF DIRECTOR

 

 

Legal Entity Identifier: 549300NFZYYFSCD52W53

Information disclosed in accordance with the UK Listing Rules 6.4.6 R (1) and 6.4.8 R (1)

 

The Board of JPMorgan Claverhouse Investment Trust plc (the 'Company') is pleased to announce the appointment of Mr. Graham Oldroyd as a Non-Executive Director of the Company with effect from the conclusion of the Annual General Meeting to be held on 7th May 2026. On appointment, Mr Oldroyd will serve as Senior Independent Director (SID) and Chairman of the Management Engagement Committee.

 

Mr. Oldroyd is an experienced Director with strong international leadership profile in private equity and industry, combining wide sector knowledge and in-depth expertise in strategic investment, mergers and acquisitions, joint ventures and business development.

 

Mr. Oldroyd is currently a Non-Executive Director of Senior plc, Deputy Chairman of Videndum plc and Chairman of The Global Smaller Companies Trust PLC.

 

Mr. Oldroyd does not own any shares of the Company.

 

The Company discloses this information pursuant to the Financial Conduct Authority's UK Listing Rules 6.4.6 R (1) and 6.4.8 R (1). No further information is to be disclosed pursuant to UK Listing Rules 6.4.8 R (2) to 6.4.8 R (6) in respect of Mr. Oldroyd.

 

 

25th March 2026

 

 

For further information, please contact:

Anmol Dhillon

JPMorgan Funds Limited, Company Secretary

0800 20 40 20 (or +44 1268 44 44 70)

 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
 
END
 
 
BOABCGDXDBDDGLS
Date   Source Headline
10th Sep 20254:32 pmRNSTen Largest Investments
10th Sep 202510:58 amRNSNet Asset Value(s)
9th Sep 202511:20 amRNSNet Asset Value(s)
8th Sep 202512:18 pmRNSGearing announcement
8th Sep 202511:42 amRNSNet Asset Value(s)
5th Sep 202511:17 amRNSNet Asset Value(s)
4th Sep 202511:05 amRNSNet Asset Value(s)
3rd Sep 202510:56 amRNSNet Asset Value(s)
2nd Sep 202510:48 amRNSNet Asset Value(s)
1st Sep 202512:51 pmRNSGearing Announcement
1st Sep 202511:46 amRNSNet Asset Value(s)
1st Sep 20259:35 amRNSTotal Voting Rights
29th Aug 202511:36 amRNSNet Asset Value(s)
28th Aug 202511:34 amRNSNet Asset Value(s)
27th Aug 202511:05 amRNSNet Asset Value(s)
26th Aug 20251:32 pmRNSGearing Announcement
26th Aug 202512:24 pmRNSNet Asset Value(s)
22nd Aug 202511:26 amRNSNet Asset Value(s)
21st Aug 202511:06 amRNSNet Asset Value(s)
20th Aug 202511:01 amRNSNet Asset Value(s)
19th Aug 202510:36 amRNSNet Asset Value(s)
18th Aug 20253:05 pmRNSGearing Announcement
18th Aug 202511:13 amRNSNet Asset Value(s)
15th Aug 202511:09 amRNSNet Asset Value(s)
14th Aug 202510:49 amRNSNet Asset Value(s)
14th Aug 20257:00 amRNSHalf-year Report
13th Aug 202510:50 amRNSNet Asset Value(s)
12th Aug 20254:34 pmRNSTen Largest Investments
12th Aug 202511:45 amRNSNet Asset Value(s)
11th Aug 202512:56 pmRNSGearing announcement
11th Aug 202512:13 pmRNSNet Asset Value(s)
8th Aug 202510:52 amRNSNet Asset Value(s)
7th Aug 202510:53 amRNSNet Asset Value(s)
6th Aug 202511:04 amRNSNet Asset Value(s)
5th Aug 20255:03 pmRNSTransaction in Own Shares
5th Aug 202511:26 amRNSNet Asset Value(s)
4th Aug 202511:24 amRNSGearing announcement
4th Aug 202511:04 amRNSNet Asset Value(s)
1st Aug 20255:04 pmRNSTransaction in Own Shares
1st Aug 202511:23 amRNSNet Asset Value(s)
1st Aug 20259:26 amRNSTotal Voting Rights
31st Jul 20255:08 pmRNSTransaction in Own Shares
31st Jul 202510:45 amRNSNet Asset Value(s)
30th Jul 202510:35 amRNSNet Asset Value(s)
29th Jul 202510:40 amRNSNet Asset Value(s)
28th Jul 202511:10 amRNSGearing Announcement
28th Jul 202510:34 amRNSNet Asset Value(s)
25th Jul 202511:10 amRNSNet Asset Value(s)
24th Jul 202511:11 amRNSNet Asset Value(s)
23rd Jul 202510:28 amRNSNet Asset Value(s)

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.